Puberty Blocker, Cross-Sex Hormone Prescriptions Double in America’s Children Since 2017

Susan Berry, PhD, The Star News Network

Health insurance claims data for treatment of gender dysphoria in children aged 6-17 years

shows puberty blocker prescriptions have doubled since 2017, and claims for cross-sex hormones also doubled up until 2021. According to data compiled by Komodo Health Inc for Reuters in October, in 2021, 42,167 children and teens between the ages of 6 and 17 were diagnosed with gender dysphoria, three times the number in 2017. It's out of control.